Literature DB >> 9024233

Mild clinical expression of myasthenia gravis associated with autoimmune thyroid diseases.

M Marinó1, R Ricciardi, A Pinchera, G Barbesino, L Manetti, L Chiovato, L E Braverman, B Rossi, A Muratorio, S Mariotti.   

Abstract

Myasthenia gravis (MG) may occur in association with autoimmune thyroid diseases (AITD). The aim of this study was to evaluate the features of MG associated with AITD compared to those of MG without AITD. A total of 129 MG patients (34 men and 95 women; age range, 11-81 yr) were subdivided into: group A, 56 MG patients with AITD [25 with autoimmune thyroiditis and 31 with Graves' disease (GD)]; group B, 21 MG patients with nonautoimmune thyroid diseases; and group C, 52 MG patients without thyroid disease. The severity of MG was ranked according to the Osserman score. Laboratory evaluation included assays for antithyroid and antiacetylcholine receptor (AchRAb) antibodies. Ocular MG (Osserman's class 1) was more frequent in group A (41.0%) than in group B (14.2%; P < 0.03) or C (21.4%; P < 0.03). Severe generalized MG (classes > or = 2B) was more frequent in groups B (57.1%; P < 0.03) and C (51.9%; P < 0.02) than in group A (28.5%). GD patients with clinical evidence of ophthalmopathy had a higher frequency (P = 0.05) of ocular MG (57.8%) than GD patients without clinical ophthalmopathy (16.6%). Thymic disease was less frequent in group A (26.7%) than in group B (71.4%; P = 0.001) or C (59.7%; P = 0.001). The prevalence of thymic hyperplasia was 17.8%, 38.0%, and 40.3% in groups A, B, and C, respectively; the prevalence of thymoma was 8.9%, 33.4%, and 19.4%. When only patients with generalized MG were considered, thymic disease was less frequent (P < 0.02) in group A (40.6%) than in the remaining groups (69.4%). AchRAb was more frequent in groups B (57.1%) and C (57.6%; P < 0.03) than in group A (35.7%). In conclusion, MG associated with AITD has a mild clinical expression, with preferential ocular involvement and lower frequency of thymic disease and AchRAb. This supports the hypothesis that ocular and generalized MG are separate diseases with different spectra of associated diseases. Nonautoimmune thyroid diseases have no influence on the features of MG. The association of ocular MG and AITD might be due to a common autoimmune mechanism and/or a peculiar genetic background.

Entities:  

Mesh:

Year:  1997        PMID: 9024233     DOI: 10.1210/jcem.82.2.3749

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  26 in total

1.  Association of systemic and thyroid autoimmune diseases.

Authors:  Edit Biró; Zoltán Szekanecz; László Czirják; Katalin Dankó; Emese Kiss; Nóra Anna Szabó; Gabriella Szucs; Margit Zeher; Edit Bodolay; Gyula Szegedi; Gyula Bakó
Journal:  Clin Rheumatol       Date:  2005-10-25       Impact factor: 2.980

2.  Temporal coincidence of myasthenia gravis and Guillain Barré syndrome associated with Hashimoto thyroiditis.

Authors:  Jing Ye Wang; Jie Pan; Ben Yan Luo; Yan Yan Zhang
Journal:  Neurol Sci       Date:  2011-04-14       Impact factor: 3.307

3.  Autoimmune thyroid disease with myasthenia gravis in a 28-year-old male: a case report.

Authors:  Imran Masood; Mir Yasir; Aiffa Aiman; R P Kudyar
Journal:  Cases J       Date:  2009-09-14

4.  Guillain-Barré syndrome and myasthenia gravis in the context of autoimmune polyendocrine syndrome type III.

Authors:  Marianna Gabriella Rispoli; Laura Ferri; Paola Ajdinaj; Valeriana Falzano; Antonio Di Muzio
Journal:  Neurol Sci       Date:  2021-07-31       Impact factor: 3.307

5.  Concomitant autoimmunity in myasthenia gravis--lack of association with IgA deficiency.

Authors:  Ryan Ramanujam; Fredrik Piehl; Ritva Pirskanen; Peter K Gregersen; Lennart Hammarström
Journal:  J Neuroimmunol       Date:  2011-06-12       Impact factor: 3.478

6.  Prevalence of interrelated autoantibodies in thyroid diseases and autoimmune disorders.

Authors:  H Nakamura; T Usa; M Motomura; T Ichikawa; K Nakao; E Kawasaki; M Tanaka; K Ishikawa; K Eguchi
Journal:  J Endocrinol Invest       Date:  2008-10       Impact factor: 4.256

7.  Hickam's dictum: Myasthenia Gravis presenting concurrently with Graves' disease.

Authors:  Shekhar Sehgal; Roshan Rebello; Louise Wolmarans; Marianne Elston
Journal:  BMJ Case Rep       Date:  2017-09-07

8.  Severe asthma associated with myasthenia gravis.

Authors:  Natasha Satkunam; Zaeem A Siddiqi; Dilini Vethanayagam
Journal:  Can Respir J       Date:  2013-09-12       Impact factor: 2.409

9.  Dual attack: targeting the rare co-occurrence of myasthenia gravis and Graves' disease with radioactive iodine therapy.

Authors:  Anna Elvira S Arcellana; Karen Joy B Adiao; Myrna Buenaluz-Sedurante
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2021-07-01

10.  Disappearance of Anti-Thyroid Autoantibodies following Thymectomy in Patients with Myasthenia Gravis.

Authors:  Giovanna Rotondo Dottore; Marenza Leo; Roberta Ricciardi; Michelangelo Maestri; Ilaria Bucci; Marco Lucchi; Franca Melfi; Melania Guida; Anna De Rosa; Loredana Petrucci; Ilaria Ionni; Giulia Lanzolla; Francesca Nicolì; Michele Mantuano; Debora Ricci; Francesco Latrofa; Stefano Mariotti; Claudio Marcocci; Michele Marinò
Journal:  Eur Thyroid J       Date:  2020-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.